These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21699581)

  • 1. Editorial comment to effect of hyaluronic acid on urine nerve growth factor in cyclophosphamide-induced cystitis.
    Masuda H
    Int J Urol; 2011 Jul; 18(7):531-2. PubMed ID: 21699581
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of hyaluronic acid on urine nerve growth factor in cyclophosphamide-induced cystitis.
    Ho DR; Chen CS; Lin WY; Chang PJ; Huang YC
    Int J Urol; 2011 Jul; 18(7):525-31. PubMed ID: 21605172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial Comment from Dr Kitta to effect of intrathecal administration of E-series prostaglandin 1 receptor antagonist in a cyclophosphamide-induced cystitis rat model.
    Kitta T
    Int J Urol; 2013 Feb; 20(2):241. PubMed ID: 22973832
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial comment on: Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection.
    Novara G
    Eur Urol; 2009 Oct; 56(4):706-7. PubMed ID: 18472211
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased nerve growth factor in neurogenic overactive bladder and interstitial cystitis patients.
    Jacobs BL; Smaldone MC; Tyagi V; Philips BJ; Jackman SV; Leng WW; Tyagi P
    Can J Urol; 2010 Feb; 17(1):4989-94. PubMed ID: 20156378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial comment on: Intravesical botulinum toxin A administration inhibits COX-2 and EP4 expression and suppresses bladder hyperactivity in cyclophosphamide-induced cystitis in rats.
    Giannantoni A
    Eur Urol; 2009 Jul; 56(1):166-7. PubMed ID: 18514387
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial comment on: Intravesical botulinum toxin A administration inhibits COX-2 and EP4 expression and suppresses bladder hyperactivity in cyclophosphamide-induced cystitis in rats.
    Vignozzi L; Morelli A
    Eur Urol; 2009 Jul; 56(1):166. PubMed ID: 18514385
    [No Abstract]   [Full Text] [Related]  

  • 8. Have we been led astray by the NGF biomarker data?
    Gamper M; Moser R; Viereck V
    Neurourol Urodyn; 2017 Jan; 36(1):203-204. PubMed ID: 26384156
    [No Abstract]   [Full Text] [Related]  

  • 9. Improvement by phytotherapeutic agent of detrusor overactivity, down-regulation of pharmacological receptors and urinary cytokines in rats with cyclophosphamide induced cystitis.
    Nasrin S; Masuda E; Kugaya H; Ito Y; Yamada S
    J Urol; 2013 Mar; 189(3):1123-9. PubMed ID: 23000860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial Comment to Intravesical hyaluronic acid treatment improves bacterial cystitis and reduces cystitis-induced hypercontractility in rats.
    Damiano R; Cantiello F; Cicione A
    Int J Urol; 2015 Jun; 22(6):604. PubMed ID: 25808703
    [No Abstract]   [Full Text] [Related]  

  • 11. The influence of piroxicam, a non-selective cyclooxygenase inhibitor, on autonomic nervous system activity in experimental cyclophosphamide-induced hemorrhagic cystitis and bladder outlet obstruction in rats.
    Dobrek Ł; Baranowska A; Skowron B; Thor PJ
    Acta Pol Pharm; 2014; 71(3):497-507. PubMed ID: 25265830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial Comment from Dr Ishizuka to effect of intrathecal administration of E-series prostaglandin 1 receptor antagonist in a cyclophosphamide-induced cystitis rat model.
    Ishizuka O
    Int J Urol; 2013 Feb; 20(2):240. PubMed ID: 22958174
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of Intravesical Liposome-Based Nerve Growth Factor Antisense Therapy on Bladder Overactivity and Nociception in a Rat Model of Cystitis Induced by Hydrogen Peroxide.
    Majima T; Tyagi P; Dogishi K; Kashyap M; Funahashi Y; Gotoh M; Chancellor MB; Yoshimura N
    Hum Gene Ther; 2017 Jul; 28(7):598-609. PubMed ID: 28446032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary nerve growth factor but not prostaglandin E2 increases in patients with interstitial cystitis/bladder pain syndrome and detrusor overactivity.
    Liu HT; Tyagi P; Chancellor MB; Kuo HC
    BJU Int; 2010 Dec; 106(11):1681-5. PubMed ID: 19751258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rho kinase inhibition ameliorates cyclophosphamide-induced cystitis in rats.
    Wróbel A; Doboszewska U; Rechberger E; Rojek K; Serefko A; Poleszak E; Skalicka-Woźniak K; Dudka J; Wlaź P
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):613-619. PubMed ID: 28220212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [NERVE GROWTH FACTOR IN THE URINE OF PATIENTS WITH IDIOPATHIC DETRUSOR OVERACTIVITY AND OVERACTIVE BLADDER WITHOUT DETRUSOR OVERACTIVITY].
    Krivoborodov GG; Kolesanova EF; Tur EI; Efremov NS
    Urologiia; 2015; (3):19-22. PubMed ID: 26390554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NGF and HB-EGF: potential biomarkers that reflect the effects of fesoterodine in patients with overactive bladder syndrome.
    Kim SR; Moon YJ; Kim SK; Bai SW
    Yonsei Med J; 2015 Jan; 56(1):204-11. PubMed ID: 25510766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of silymarin on bladder overactivity in cyclophosphamide-induced cystitis rat model.
    Eser N; Göçmen C; Erdoğan S; Büyüknacar HS; Kumcu EK; Açıkalın A; Önder S
    Phytomedicine; 2012 Jun; 19(8-9):840-5. PubMed ID: 22647456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary nerve growth factor correlates with the severity of urgency and pain: methodological evaluation.
    Agilli M; Aydin FN; Kurt YG; Cayci T
    Int Urogynecol J; 2015 Mar; 26(3):459. PubMed ID: 25335749
    [No Abstract]   [Full Text] [Related]  

  • 20. Functional characterization of a chronic cyclophosphamide-induced overactive bladder model in mice.
    Boudes M; Uvin P; Kerselaers S; Vennekens R; Voets T; De Ridder D
    Neurourol Urodyn; 2011 Nov; 30(8):1659-65. PubMed ID: 21717507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.